Literature DB >> 19089970

Electrosurgical energy in combination with a transseptal needle: a novel method for the creation of an atrial communication in hypoplastic left heart syndrome with intact atrial septum.

Brent M Gordon1, Daniel S Levi, Kevin M Shannon.   

Abstract

Neonates with hypoplastic left heart syndrome (HLHS) and intact atrial septum (IAS) usually present with severe acidosis and hypoxemia that necessitate immediate intervention to create an atrial septal defect (ASD). Transcatheter creation of an ASD in these patients requires transseptal puncture of a thickened atrial septum in the setting of a very small left atrium. We report on a novel method of perforating the atrial septum using radio-frequency energy in combination with a transseptal needle to facilitate transseptal puncture and subsequent stent placement in a very thick atrial septum of a newborn with HLHS/IAS and a small left atrium. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19089970     DOI: 10.1002/ccd.21754

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Retrograde Pulmonary Vein Recanalization Using Transcatheter Electrosurgery.

Authors:  Saleem I Almasarweh; James A Kuo; Holly D Bauser-Heaton; Vasilis C Babaliaros; Dennis W Kim
Journal:  JACC Case Rep       Date:  2022-05-18

2.  Novel transatrial septoplasty technique for neonates with hypoplastic left heart syndrome and an intact or highly restrictive atrial septum.

Authors:  Kevin Hill; J Curt Fudge; Piers Barker; James Jaggers; John Rhodes
Journal:  Pediatr Cardiol       Date:  2010-01-05       Impact factor: 1.655

Review 3.  Transcatheter Electrosurgery: JACC State-of-the-Art Review.

Authors:  Jaffar M Khan; Toby Rogers; Adam B Greenbaum; Vasilis C Babaliaros; Dursun Korel Yildirim; Christopher G Bruce; Daniel A Herzka; William H Schenke; Kanishka Ratnayaka; Robert J Lederman
Journal:  J Am Coll Cardiol       Date:  2020-03-31       Impact factor: 24.094

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.